Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell cycle on the crossroad of tumorigenesis and cancer therapy
Jing Liu, Yunhua Peng, Wenyi Wei
Trends in Cell Biology (2021) Vol. 32, Iss. 1, pp. 30-44
Open Access | Times Cited: 237

Showing 1-25 of 237 citing articles:

RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 167
Pathological implication of protein post-translational modifications in cancer
Sheng Pan, Ru Chen
Molecular Aspects of Medicine (2022) Vol. 86, pp. 101097-101097
Open Access | Times Cited: 110
Potential of Copper and Copper Compounds for Anticancer Applications
Peng Ji, Peng Wang, Hao Chen, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 234-234
Open Access | Times Cited: 78
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 37
Histone lactylation: from tumor lactate metabolism to epigenetic regulation
Xiaoning Yu, Jing Yang, Jin Xu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1833-1854
Open Access | Times Cited: 16
Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review
Sara Abdolmaleki, Alireza Aliabadi, Samad Khaksar
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 14
Emerging tumor-on-chips with electrochemical biosensors
Lanjie Lei, Biao Ma, Chengtao Xu, et al.
TrAC Trends in Analytical Chemistry (2022) Vol. 153, pp. 116640-116640
Closed Access | Times Cited: 46
Structure, anti-tumor activity, and potential anti-tumor mechanism of a fungus polysaccharide from Fomes officinalis
Shaojie Zhang, Yeling Li, Zhengguo Li, et al.
Carbohydrate Polymers (2022) Vol. 295, pp. 119794-119794
Closed Access | Times Cited: 41
Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest
Reece Foy, Lisa Crozier, Aanchal Udaynath Pareri, et al.
Molecular Cell (2023) Vol. 83, Iss. 22, pp. 4047-4061.e6
Open Access | Times Cited: 32
Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?
Opeyemi Iwaloye, Paul Olamide Ottu, Femi Olawale, et al.
Informatics in Medicine Unlocked (2023) Vol. 41, pp. 101332-101332
Open Access | Times Cited: 28
CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties
Mengzhu Lv, Ying Gong, Xuesong Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 21
Withanolides: Promising candidates for cancer therapy
Qiang Zhang, Yongkang Yuan, Shijie Cao, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 2, pp. 1104-1158
Closed Access | Times Cited: 6
Assessment of Mononuclear/Dinuclear copper acylhydrazone complexes for lung cancer treatment
YouRu Wu, D. Christine Wu, Jianfeng Lan, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107122-107122
Closed Access | Times Cited: 6
Research progress on the pharmacological mechanism, in vivo metabolism and structural modification of Erianin
Xin Wei, Jiajia Liu, Ziming Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116295-116295
Open Access | Times Cited: 6
Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence
Jin Zhang, Yue Ma
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116909-116909
Open Access | Times Cited: 6
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Identification and validation of CDK1 as a promising therapeutic target for Eriocitrin in colorectal cancer: a combined bioinformatics and experimental approach
Jiemiao Shen, Xing Gong, Haili Ren, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Calothrixin B by docking JAK2 is a potential therapeutic inhibitor for pancreatic ductal adenocarcinoma
Yang Wang, Sayed S. Esa, Rongji Yu, et al.
Journal of Pharmacy and Pharmacology (2025)
Closed Access
A comprehensive multi-omics study reveals potential prognostic and diagnostic biomarkers for colorectal cancer
Mohita Mahajan, Subodh Dhabalia, Tirtharaj Dash, et al.
International Journal of Biological Macromolecules (2025), pp. 140443-140443
Closed Access
Propolis: A Detailed Insight of Its Anticancer Molecular Mechanisms
Suhib Altabbal, Khawla Athamnah, Aaesha Rahma, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 450-450
Open Access | Times Cited: 18
GDF15 Promotes Cell Growth, Migration, and Invasion in Gastric Cancer by Inducing STAT3 Activation
Mina Joo, Dong‐Hyun Kim, Myung-Won Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2925-2925
Open Access | Times Cited: 15
Research progress on the anti-tumor effect of Naringin
Jing He, Huiping Zhang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
Aadil Javed, Mahdieh Yarmohammadi, Kemal Korkmaz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2848-2848
Open Access | Times Cited: 14
Mechanistic Action of Cell Cycle Arrest and Intrinsic Apoptosis via Inhibiting Akt/mTOR and Activation of p38-MAPK Signaling Pathways in Hep3B Liver Cancer Cells by Prunetrin—A Flavonoid with Therapeutic Potential
Abuyaseer Abusaliya, Se Hyo Jeong, Pritam Bhagwan Bhosale, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3407-3407
Open Access | Times Cited: 14
Exploring therapeutic potential of Rutin by investigating its cyclin-dependent kinase 6 inhibitory activity and binding affinity
Mohd Yousuf, Shama Khan, Afzal Hussain, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130624-130624
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top